Prentice A - Search Results

1

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.

Glasmacher A, Prentice A, Gorschlüter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG. Glasmacher A, et al. Among authors: prentice a. J Clin Oncol. 2003 Dec 15;21(24):4615-26. doi: 10.1200/JCO.2003.04.052. J Clin Oncol. 2003. PMID: 14673051

2

An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.

Glasmacher A, von Lilienfeld-Toal M, Schulte S, Hahn C, Schmidt-Wolf IG, Prentice A. Glasmacher A, et al. Among authors: prentice a. Clin Microbiol Infect. 2005 Oct;11 Suppl 5:17-23. doi: 10.1111/j.1469-0691.2005.01239.x. Clin Microbiol Infect. 2005. PMID: 16138815 Free article. Review.

3

Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.

Glasmacher A, Prentice AG. Glasmacher A, et al. Among authors: prentice ag. J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i23-i32. doi: 10.1093/jac/dki221. J Antimicrob Chemother. 2005. PMID: 16120631 Review.

4

Making sense of itraconazole pharmacokinetics.

Prentice AG, Glasmacher A. Prentice AG, et al. J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i17-i22. doi: 10.1093/jac/dki220. J Antimicrob Chemother. 2005. PMID: 16120630 Review.

5

In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.

Prentice AG, Glasmacher A, Djulbegovic B. Prentice AG, et al. Br J Haematol. 2006 Mar;132(5):656-8; author reply 658-9. doi: 10.1111/j.1365-2141.2006.05967.x. Br J Haematol. 2006. PMID: 16445845 Free article. No abstract available.

6

Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.

de Vries R, Daenen S, Tolley K, Glasmacher A, Prentice A, Howells S, Christopherson H, de Jong-van den Berg LT, Postma MJ. de Vries R, et al. Among authors: prentice a. Pharmacoeconomics. 2008;26(1):75-90. doi: 10.2165/00019053-200826010-00007. Pharmacoeconomics. 2008. PMID: 18088160 Free article.

7

Prophylaxis of fungal infections with itraconazole during remission-induction therapy.

Prentice AG, Bradford GR. Prentice AG, et al. Mycoses. 1989;32 Suppl 1:96-102. doi: 10.1111/j.1439-0507.1989.tb02298.x. Mycoses. 1989. PMID: 2561190 Clinical Trial.

8

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.

Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW. Morgenstern GR, et al. Among authors: prentice ag, prentice hg. Br J Haematol. 1999 Jun;105(4):901-11. doi: 10.1046/j.1365-2141.1999.01465.x. Br J Haematol. 1999. PMID: 10554799 Free article. Clinical Trial.

9

Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.

Prentice AG, Warnock DW, Johnson SA, Taylor PC, Oliver DA. Prentice AG, et al. J Antimicrob Chemother. 1995 Oct;36(4):657-63. doi: 10.1093/jac/36.4.657. J Antimicrob Chemother. 1995. PMID: 8591940 Clinical Trial.

10

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients.

Prentice AG, Warnock DW, Johnson SA, Phillips MJ, Oliver DA. Prentice AG, et al. J Antimicrob Chemother. 1994 Aug;34(2):247-52. doi: 10.1093/jac/34.2.247. J Antimicrob Chemother. 1994. PMID: 7814285 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,053 results

Search Page

Filters